id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-298287-larzpygd	Bhat, Shubha	Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic	2020-07-20		.txt	text/plain	831	48	36	title: Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic To characterize the clinical pharmacists' impact on caring for patients with inflammatory bowel disease during COVID-19. RESULTS: The clinical pharmacist addressed COVID-19 and inflammatory bowel disease treatment concerns with 140 patients, conducted 34 medication education and monitoring visits, reviewed 141 patients' charts and helped rescheduled 18 patients who missed their biologic infusion, transitioned 12 patients to home infusions, and assisted 5 patients with medication access. DISCUSSION: Clinical pharmacists embedded in gastroenterology practices permit for continued optimal patient care during a pandemic. However, the potential for clinical pharmacists to strengthen the care of patients with inflammatory bowel disease (IBD) during this pandemic has not been reported. The clinical pharmacist spoke with 140 patients to address COVID-19 and IBD treatment concerns. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic	./cache/cord-298287-larzpygd.txt	./txt/cord-298287-larzpygd.txt